Physician profile
Craig Daniel Eck
NPI 1982018594
$4,504.22
in general payments reported to CMS, 2019-2025
22 companies · $851 in 2025
The $851 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $155 · 2021: $412 · 2022: $564 · 2023: $759 · 2024: $950 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,560.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $840.04 | 2019-2025 | Hydrus Microstent, Argos, Clareon |
| Johnson & Johnson Surgical Vision, INC. | $559.23 | 2019-2025 | Tecnis Iol, Catalys System, Tecnis Iol |
| Bausch & Lomb Americas INC. | $534.32 | 2023-2025 | Envista Mx60 Iol, Stellaris, Envista Envy Iol |
| Abbvie INC. | $425.43 | 2022-2025 | Durysta, Alphagan P, Vuity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $415.12 | 2019-2021 | |
| Glaukos Corporation | $278.69 | 2019-2023 | |
| Rxsight INC | $257.94 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Contact Lens |
| Harrow Eye, LLC | $183.41 | 2024-2025 | Iheezo |
| Mallinckrodt Hospital Products INC. | $163.59 | 2021-2025 | Acthar |
| Allergan, INC. | $136.66 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $136.24 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $132.12 | 2021-2025 | |
| Sight Sciences, INC. | $131.23 | 2024 | Omni Surgical System |
| Eyevance Pharmaceuticals LLC | $97.58 | 2020-2022 | |
| Oyster Point Pharma, INC. | $58.32 | 2023-2024 | Tyrvaya |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $41.77 | 2025 | Oxervate |
| New World Medical,INC. | $25.13 | 2021 | |
| Iridex Corporation | $23.87 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Merck Sharp & Dohme LLC | $15.78 | 2021 | |
| Aerie Pharmaceuticals, INC. | $14.90 | 2021 | |
| Rayner Intraocular Lenses Limited | $13.45 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Eck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.